Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IQSEC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIVEP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM174B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTAG1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
THEMIS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPINT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADGRG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EVC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM101B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM19A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QPCT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNJ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on